FULC
Fulcrum Therapeutics Inc
3.70$
-0.5%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 30.8% | 86.4% | 90.6% | 87.1% | 96.2% | 91.5% | 94.0% | 95.9% | 97.6% | |
| 9.4% | 84.9% | 87.6% | 44.0% | 15.1% | 15.5% | 9.9% | 22.3% | 53.9% | |
| 9.4% | 84.9% | 87.6% | 87.1% | 92.8% | 89.5% | 91.7% | 92.4% | 96.2% | |
| 0.9% | 0.6% | 0.1% | 2.1% | 1.7% | 0.5% | 0.9% | 1.3% | 0.3% | |
| 16.9% | 0.7% | 2.7% | -2.1% | -0.2% | -0.2% | – | – | – | |
| 67.8% | 12.3% | 8.3% | 6.5% | 3.1% | 3.0% | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 69.5% | 11.4% | 21.1% | 26.5% | 10.0% | 12.2% | 8.7% | 6.8% | 4.7% | |
| 64.2% | 4.9% | 11.0% | 20.6% | 8.2% | 7.4% | 5.3% | 4.2% | 3.6% | |
| 0.0% | 0.1% | 0.0% | 0.0% | 4.1% | 1.1% | 0.9% | 0.8% | 0.7% | |
| 38.5% | 1.5% | 2.0% | 3.1% | 2.0% | 1.6% | 1.1% | 0.4% | 0.4% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 30.5% | 88.6% | 78.9% | 73.5% | 90.0% | 87.8% | 91.3% | 93.2% | 95.3% | |
| -818.8% | -79.4% | -136.5% | -171.0% | -128.7% | -181.9% | -197.8% | -199.2% | -162.2% | |
| 390.3% | 19.8% | 20.5% | 19.6% | 15.0% | 19.8% | 23.8% | 23.8% | 17.3% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.